“…Advances in generating synthetic riboswitches have accelerated their application as genetic controllers in the areas of molecular sensors, metabolic pathway optimization (Cress et al, ; Dietrich et al, ; Liu et al, ; McKeague et al, ; Rogers et al, ) and therapeutic applications (Davydova et al, ; Lee et al, ). In the past decade, several natural and artificial RNA‐based sensors have been engineered to respond to a wide range of metabolites, including folinic acid (Trausch et al, ), theophylline (Beisel et al, ; Lynch et al, ; Michener and Smolke, ; Topp et al, ; Wachsmuth et al, ), xanthine (Beisel et al, ), tetracycline (Beisel et al, ; Weigand and Suess, ), ammeline (Dixon et al, ), cyclic‐di‐GMP (Kellenberger et al, ; Lynch et al, ), cyclic‐di‐AMP (Kellenberger et al, ), β‐catenin (Bloom et al, ), thiamine 5′‐pyrophosphate (TPP) (You et al, ), guanine (Paige et al, ; You et al, ), adenine (You et al, ), S‐adenosyl‐methionine (SAM) (Paige et al, ; You et al, ), adenosine 5‐diphosphate (ADP) (Paige et al, ), guanosine 5‐triphosphate (GTP) (Paige et al, ), flavin mononucleotide (FMN) (Meyer et al, ), lysine (Yang et al, ; Zhou and Zeng, ), glucosamine 6‐phosphate (Lee and Oh, ) in prokaryotic, eukaryotic, and mammalian cells through various mechanisms.…”